Inhibitory actions of selected natural substances on formation of advanced glycation endproducts and advanced oxidation protein products.
BACKGROUND
Advanced glycation endproducts (AGE) and advanced oxidation protein products (AOPP) arise as a result of excessive glycation and oxidation processes of proteins in hyperglycemia and oxidative stress conditions respectively, both in vivo and in vitro. In vivo these processes are especially intensified in patients with diabetes, and the adverse effects of AGE and AOPP are particularly unfavorable for the pathogenesis and aggravate the biochemical disturbances and clinical complications of diabetes. Total AGE and AOPP (T-AGE and T-AOPP) are heterogeneous groups of compounds, and they can be divided into two main fractions: high- and low-molecular-weight, i.e. HMW-AGE and HMW-AOPP as well as LMW-AGE and LMW-AOPP. Therefore it is important to find natural substances that will prevent formation of total AGE and AOPP and their high- and low-molecular-weight fractions and thereby reduce their adverse effects on tissues and organs.


METHODS
Selected natural substances and dietary supplements such as vitamin C, aminoguanidine, quercetin and green tea as well as the multicompound formulations Padma Circosan and Padma 28 were tested in an in vitro model using bovine serum albumin (BSA). Fluorescence of T-, HMW- and LMW-AGE and concentration of T-, HMW- and LMW-AOPP were measured after incubation with these substances.


RESULTS
In the examined concentrations quercetin showed the greatest degree of inhibition for T-AGE (60.5 %) as well as for HMW-AGE (79.5 %), while in the case of LMW-AGE the greatest degree of glycation inhibition was shown by Padma Circosan (74.9 %). T-AOPP and HMW-AOPP were best inhibited by vitamin C (87.3 and 89.1 % respectively). The results obtained for LMW-AOPP are atypical, but the lowest concentration was observed in a sample with Padma 28.


CONCLUSIONS
The results show that all tested natural compounds have inhibitory activity towards the formation of total and low- and high-molecular-weight forms of AGE and AOPP in vitro. That suggest a possible role in the prevention of diabetic complications, especially the multiherbal compound Padma preparations, which are especially effective in lowering the most dangerous, i.e. LMW fractions.
Department of Pharmaceutical Biochemistry, Wroclaw Medical University, Faculty of Pharmacy, Borowska 211A St., 50-556, Wroclaw, Poland. ewa.grzebyk@gmail.com.
Ewa
http://orcid.org/0000-0002-4872-3756
E
Grzebyk
Department of Toxicology, Wroclaw Medical University, Faculty of Pharmacy, Borowska 211 St., 50-556, Wroclaw, Poland.
Agnieszka
A
Piwowar
Advanced Glycation Endproducts (AGE); Advanced Oxidation Protein Products (AOPP); Glycation; Green tea; High- and Low-Molecular-Weight fractions (HMW and LMW); Oxidation; Padma 28; Padma Circosan; Quercetin; Vitamin C
Physiol Res. 2002;51(6):597-604
12511184
BMC Complement Altern Med. 2014 Aug 05;14:287
25096528
Nature. 1970 Aug 15;227(5259):680-5
5432063
Nephrol Dial Transplant. 1999 Aug;14 (8):1968-75
10462279
Phytother Res. 2011 May;25(5):740-3
21413090
Clin Biochem Rev. 2005 Nov;26(4):123-34
16648883
Evid Based Complement Alternat Med. 2012;2012:598638
23008741
Am J Physiol Renal Physiol. 2005 Oct;289(4):F645-59
16159899
Pak J Pharm Sci. 2015 Jan;28(1):23-8
25553682
Kidney Int. 1996 May;49(5):1304-13
8731095
Mol Nutr Food Res. 2006 Dec;50(12):1140-9
17131455
Oxid Med Cell Longev. 2015;2015:983484
25628774
Acta Diabetol. 2007 Jun;44(2):83-90
17530472
Neurotox Res. 2011 Nov;20(4):372-8
21698507
Biol Trace Elem Res. 2011 Nov;143(2):717-25
21165710
Pol Merkur Lekarski. 2013 Apr;34(202):239-42
23745334
BMC Complement Altern Med. 2015 Apr 28;15:134
25928352
Pharmacol Res. 2007 May;55(5):433-40
17336542
J Agric Food Chem. 2009 Jun 10;57(11):5058-64
19489629
Kidney Int. 2004 Sep;66(3):1167-72
15327413
Nephrol Dial Transplant. 1999;14 Suppl 1:76-8
10048460
Fitoterapia. 2005 Jul;76(5):419-27
15894431
Eur J Clin Chem Clin Biochem. 1997 Sep;35(9):669-77
9352229
Food Chem Toxicol. 2013 Oct;60:10-37
23867544
Endocrinol Metab Clin North Am. 2013 Dec;42(4):697-719
24286947
BMC Complement Altern Med. 2013 May 16;13:107
23680079
Mol Nutr Food Res. 2011 Jun;55(6):844-54
21538850
Cell Biochem Funct. 2006 Sep-Oct;24(5):443-8
15991262
ISRN Ophthalmol. 2013 Jan 15;2013:343560
24563789
Food Chem. 2011 Jul 15;127(2):589-95
23140704
Diabetes Metab Res Rev. 2008 Oct;24(7):549-53
18613218
Food Chem. 2011 Sep 1;128(1):55-61
25214329
Molecules. 2012 Nov 27;17 (12 ):14037-45
23187287
Ann Nutr Metab. 2010;57(1):40-9
20668372
J Agric Food Chem. 1999 Feb;47(2):633-6
10563944
Food Funct. 2013 Dec;4(12):1835-42
24191276
Arch Biochem Biophys. 2003 Nov 1;419(1):31-40
14568006
Biochim Biophys Acta. 2015 Jan;1850(1):1-12
25280629
Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):189-96
15386808
Mol Metab. 2013 Dec 07;3(2):94-108
24634815
Ann N Y Acad Sci. 2005 Jun;1043:644-54
16037288
J Am Soc Nephrol. 1998 Feb;9(2):277-83
9527404
Food Chem. 2013 Feb 15;136(3-4):1405-13
23194541